Journal for ImmunoTherapy of Cancer
Q1 Journal
Open Access
Journal
Country
United Kingdom
Western Europe
Subject Area and Category
Biochemistry, Genetics and Molecular Biology
└
Cancer Research
Q1
└
Immunology
Q1
└
Immunology and Allergy
Q1
Publisher
SJR 2025
4.114
Q1
SJR Score
H-Index
155
Citations / Doc (2yr)
9.58
Total Docs. (latest)
688
Total Citations (3yr)
14,995
Publication type
Journals
ISSN
20511426
Coverage
2013-2026
Journal Rank
#415
Subject Categories
Cancer Research
Q1
Immunology
Q1
Immunology and Allergy
Q1
Molecular Medicine
Q1
Oncology
Q1
Pharmacology
Q1
Subject Areas
Aims & Scope
The Journal for ImmunoTherapy of Cancer (JITC) is the open access, peer reviewed, online journal of the Society for Immunotherapy of Cancer (SITC).
The journal publishes articles on all aspects of tumor immunology and cancer immunotherapy and, in doing so, aims to enrich communication and advance scientific understanding among the many stakeholders in this rapidly evolving field.
Topics of interest range widely across the basic science-translational-clinical spectrum and include tumor-host interactions, the tumor microenvironment, animal models, predictive and prognostic immune biomarkers, novel pharmaceutical and cellular therapies, vaccines, combination immune-based therapies, and immune-related toxicity.
Abstracting & Indexing
Scopus
Google Scholar
Directory of Open Access Journals (DOAJ)
Web of Science
Medline
PubMed
Embase
Detailed Metrics
| Total Docs. (latest) | 688 |
| Total Docs. (3 years) | 1,437 |
| Total Refs. | 30,301 |
| Total Citations (3 years) | 14,995 |
| Citable Docs. (3 years) | 1,406 |
| Citations / Doc. (2 years) | 9.58 |
| Ref. / Doc. | 44.04 |
| % Female | 44.3% |
Metrics Visualization
Latest year data vs 3-year cumulative figures
Publication & Citation Trend
Loading trend data from Crossref...
Top 10 Most Cited Articles
Loading articles...
Researcher Reviews
Write a ReviewNo reviews yet for this journal.
Be the first to share your experience!
Share Your Experience
Your review will be published after moderation. Email will not be displayed publicly.